DK524484A - Furylderivater af 16-substituerede prostaglandiner og fremgangsmaadetil fremstilling heraf - Google Patents

Furylderivater af 16-substituerede prostaglandiner og fremgangsmaadetil fremstilling heraf Download PDF

Info

Publication number
DK524484A
DK524484A DK524484A DK524484A DK524484A DK 524484 A DK524484 A DK 524484A DK 524484 A DK524484 A DK 524484A DK 524484 A DK524484 A DK 524484A DK 524484 A DK524484 A DK 524484A
Authority
DK
Denmark
Prior art keywords
furily
prostaglandines
procedures
derivatives
substituted
Prior art date
Application number
DK524484A
Other languages
English (en)
Other versions
DK524484D0 (da
Inventor
Franco Faustini
Achille Panzeri
Fabrizio Orzi
Enrico Di Salle
Roberto Ceserani
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK524484D0 publication Critical patent/DK524484D0/da
Publication of DK524484A publication Critical patent/DK524484A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
DK524484A 1983-11-04 1984-11-02 Furylderivater af 16-substituerede prostaglandiner og fremgangsmaadetil fremstilling heraf DK524484A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838329559A GB8329559D0 (en) 1983-11-04 1983-11-04 Furyl derivatives of 16-substituted prostaglandins preparations

Publications (2)

Publication Number Publication Date
DK524484D0 DK524484D0 (da) 1984-11-02
DK524484A true DK524484A (da) 1985-05-05

Family

ID=10551287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524484A DK524484A (da) 1983-11-04 1984-11-02 Furylderivater af 16-substituerede prostaglandiner og fremgangsmaadetil fremstilling heraf

Country Status (18)

Country Link
US (1) US4585791A (da)
JP (1) JPS60112782A (da)
AU (1) AU563999B2 (da)
BE (1) BE900959A (da)
CH (1) CH663413A5 (da)
DE (1) DE3439863A1 (da)
DK (1) DK524484A (da)
FI (1) FI844273L (da)
FR (1) FR2554448B1 (da)
GB (2) GB8329559D0 (da)
GR (1) GR80822B (da)
HU (1) HU193708B (da)
IL (1) IL73395A0 (da)
IT (1) IT1177095B (da)
NL (1) NL8403307A (da)
SE (1) SE8405514L (da)
SU (1) SU1489582A3 (da)
ZA (1) ZA848551B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5741810A (en) 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams
US7960378B2 (en) * 2008-03-18 2011-06-14 Allergan, Inc. Therapeutic compounds
EP2297084A1 (en) * 2008-04-24 2011-03-23 Allergan, Inc. Therapeutic compounds
CA2722403C (en) 2008-04-24 2017-03-07 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
CA2723894A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic substituted hydantoins, and related compounds
EP2303836A1 (en) * 2008-05-09 2011-04-06 Allergan, Inc. Therapeutic cyclopentane derivatives
US7981887B2 (en) 2008-05-09 2011-07-19 Allergan, Inc. Therapeutic compounds
WO2009137412A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
CN106748951B (zh) 2012-07-19 2020-07-24 开曼化学股份有限公司 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
NO143741C (no) * 1972-07-13 1981-04-08 Pfizer Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins

Also Published As

Publication number Publication date
FR2554448B1 (fr) 1987-07-24
BE900959A (fr) 1985-05-02
SU1489582A3 (ru) 1989-06-23
SE8405514L (sv) 1985-05-05
CH663413A5 (de) 1987-12-15
IL73395A0 (en) 1985-02-28
GB8329559D0 (en) 1983-12-07
HU193708B (en) 1987-11-30
US4585791A (en) 1986-04-29
AU3494584A (en) 1985-05-09
SE8405514D0 (sv) 1984-11-02
IT8423390A1 (it) 1986-04-30
GB8427678D0 (en) 1984-12-05
IT8423390A0 (it) 1984-10-30
NL8403307A (nl) 1985-06-03
JPS60112782A (ja) 1985-06-19
DE3439863A1 (de) 1985-05-23
FI844273A0 (fi) 1984-10-31
GB2149788B (en) 1987-04-08
HUT35637A (en) 1985-07-29
FI844273L (fi) 1985-05-05
FR2554448A1 (fr) 1985-05-10
GB2149788A (en) 1985-06-19
IT1177095B (it) 1987-08-26
AU563999B2 (en) 1987-07-30
GR80822B (en) 1985-03-04
ZA848551B (en) 1985-06-26
DK524484D0 (da) 1984-11-02

Similar Documents

Publication Publication Date Title
DK165321C (da) Oxiranderivater og fremgangsmaade til fremstilling deraf
DK566484D0 (da) Dihydropyridinderivat og fremgangsmaade til fremstilling deraf
DK493583A (da) Azolderivater og fremgangsmaade til fremstilling deraf
DK76286D0 (da) Derivater af humant alfa1-antitrypsin og fremgangsmaade til fremstilling deraf
DK157683A (da) N-phosphonomethylglycinderivater og fremgangsmaade til fremstilling og anvendelse deraf
DK524484D0 (da) Furylderivater af 16-substituerede prostaglandiner og fremgangsmaadetil fremstilling heraf
DK350883D0 (da) Fremgangsmade til fremstilling af mycaminosyltylonolid og beslaegtede macrolidderivater og mellemprodukter herved
DK202483D0 (da) Fremgangsmade til fremstilling af substituerede iminoderivateraf dihydrobenzopyran og dihydrobenzothiopyran
DK621484D0 (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
ES537338A0 (es) Derivados de pirazol-piridina
DK343684D0 (da) Phenyletherderivater og fremgangsmaade til fremstilling deraf
DK203384D0 (da) Immobilisering af proteiner
DK445784D0 (da) Fluorenylalkylimidazol-derivater og fremgangsmaade til fremstilling deraf
DK596784D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
DK135684A (da) 2-cyano-imidazopyridin-derivater og fremgangsmaade til fremstilling heraf
DK572782A (da) Estere af 4-hydroxymethyl-1-phthalazonderivater og fremgangsmaade til fremstilling deraf
DK84183D0 (da) Benzyletherderivater af pentiter og fremgangsmade til fremstilling deraf
DK90083D0 (da) Isoxazolopyrimidinderivater og fremgangsmade til fremstilling deraf
DK284184D0 (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf
DK596884D0 (da) Phenylderivater og fremgangsmaade til fremstilling deraf
ES529614A0 (es) Procedimiento de preparar 2-trifluometil-4, 6-dinitrofenol y sus derivados
DK139484D0 (da) Fremgangsmaade til fremstilling af cephalosporin c
NO831490L (no) Cykliske imidatestere og fremgangsmaate for fremstilling derav
DK47184D0 (da) Benzazepin-derivater og fremgangsmaade til fremstilling deraf
ES532870A0 (es) Procedimiento de preparar derivados de la s-carboximetilcisteina

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment